Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 619 pseudogene (RNU6-619P) is a non-coding RNA pseudogene found in the human genome[6][5]. It is classified as a pseudogene because it is derived from the U6 small nuclear RNA (snRNA) gene sequence but does not produce a functional RNA product. U6 snRNA is an essential component of the spliceosome complex, crucial for catalyzing the removal of introns from pre-mRNA during RNA splicing in the nucleus of eukaryotic cells[1][3][7]. However, RNU6-619P itself, as a pseudogene, is typically not transcribed into a functional or catalytically active RNA and is not implicated in therapeutic targeting, biological regulation, or human disease processes. As such, it does not belong to conventional molecular families like enzymes, receptors, or transporters, and there are no known drugs, mechanisms of action, or biomarker applications associated with this pseudogene[6][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 619, pseudogene (RNU6-619P).